Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUANG, GIGI GEORGIANA | 1 | 31.7% | +30.6% |
| REDDIG, PETER J | 1 | 58.1% | +39.9% |
| SUN, GEORGE | 1 | 69.2% | +33.9% |
| JONES-FOSTER, ERICA NICOLE | 1 | 50.0% | +47.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18268434 | PHARMACEUTICAL COMPOSITION FOR AMELIORATING MALIGNANT DISEASES | REDDIG, PETER J | 21d |
| 18268052 | EASY-ASSEMBLY BED, MULTIPURPOSE TABLE, AND TRANSPORTATION LIGHTWEIGHT BOARD | SUN, GEORGE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17311574 | COLLAGEN SOLID, METHOD FOR PRODUCING COLLAGEN SOLID, BIOMATERIAL, AND EX VIVO MATERIAL | JONES-FOSTER, ERICA NICOLE | 14d |
| 18268434 | PHARMACEUTICAL COMPOSITION FOR AMELIORATING MALIGNANT DISEASES | REDDIG, PETER J | 21d |
| 18253096 | EYEDROPS FOR AMELIORATING OR PREVENTING RETINAL CIRCULATION DISORDER AND RETINAL NEUROVASCULAR COUPLING DISORDER | HUANG, GIGI GEORGIANA | — |
| 18268052 | EASY-ASSEMBLY BED, MULTIPURPOSE TABLE, AND TRANSPORTATION LIGHTWEIGHT BOARD | SUN, GEORGE | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| 1646 | 1 |
| 3673 | 1 |
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18253096 | EYEDROPS FOR AMELIORATING OR PREVENTING RETINAL CIRCULATION DISORDER AND RETINAL NEUROVASCULAR COUPLING DISORDER | HUANG, GIGI GEORGIANA | 1613 | §103 | Final Rejection | — | Pending | Aug 23, 2023 |
| 18268434 | PHARMACEUTICAL COMPOSITION FOR AMELIORATING MALIGNANT DISEASES | REDDIG, PETER J | 1646 | §102§103§112Other | Non-Final OA | 21d | Pending | Jun 20, 2023 |
| 18268052 | EASY-ASSEMBLY BED, MULTIPURPOSE TABLE, AND TRANSPORTATION LIGHTWEIGHT BOARD | SUN, GEORGE | 3673 | §102§103 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 17311574 | COLLAGEN SOLID, METHOD FOR PRODUCING COLLAGEN SOLID, BIOMATERIAL, AND EX VIVO MATERIAL | JONES-FOSTER, ERICA NICOLE | 1656 | §103 | Final Rejection | 14d | Pending | Jun 07, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial